Categories Earnings, Retail

Canada Goose Holdings (NYSE: GOOS): Q3 2020 Earnings Snapshot

— Canada Goose Holdings Inc. (NYSE: GOOS) reported its third-quarter 2020 adjusted earnings of CAD1.08 per share versus CAD1.07 per share expected.

— Total revenue grew by 13% to CAD452.1 million versus CAD448.18 million expected.

Earnings Update by AlphaStreet

— DTC revenue jumped by 28% driven by incremental revenue from new retail stores. Retail revenue in Hong Kong was severely impacted by disruptions to tourism and retail traffic, together with frequent reductions to regular store operating hours and unplanned store closures.

— Wholesale revenue decreased by 8% due to a higher proportion of total order shipments occurring in the first half of fiscal 2020 relative to last year.

— The coronavirus outbreak has a material negative impact on performance in the current fourth-quarter. The health crisis has resulted in a sharp decline in customer traffic and purchasing activity.

— Retail stores and e-commerce across Greater China continue to experience significant reductions in revenue. Due to global travel disruptions, retail stores in international shopping destinations in North America and Europe are also affected.

— For fiscal 2020, the company expects revenue to grow by 13.8-15% to CAD945-955 million while adjusted earnings are set to be in the CAD1.33-1.37 per share range. The consensus estimates EPS of CAD1.68 on revenue of CAD1.03 billion.

Browse through our earnings calendar and get all scheduled earnings announcements, analyst/investor conference and much more!

Most Popular

United Parcel Service (UPS) seems on track to regain lost strength

Cargo giant United Parcel Service, Inc. (NYSE: UPS) ended fiscal 2023 on a weak note, reporting lower revenues and profit for the fourth quarter. The company experienced a slowdown post-pandemic

IPO Alert: What to look for when Boundless Bio goes public

Boundless Bio is preparing to debut on the Nasdaq stock market this week, and become the latest addition to the list of biotech firms that have launched IPOs this year.

Nike (NKE) bets on innovation and partnerships to return to high growth

Sneaker giant Nike, Inc. (NYSE: NKE) has been going through a rough patch for some time, with sales coming under pressure from weak demand and rising competition. Post-pandemic, the company

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top